Literature DB >> 25784755

Reply to "A truncation in the regulator RocA underlies heightened capsule expression in serotype M3 group A streptococci".

Eric W Miller1, Kathryn J Pflughoeft1, Paul Sumby2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25784755      PMCID： PMC4363452          DOI： 10.1128/IAI.03162-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  5 in total

1.  Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus.

Authors:  Stephen B Beres; Ellen W Richter; Michal J Nagiec; Paul Sumby; Stephen F Porcella; Frank R DeLeo; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  RivR is a negative regulator of virulence factor expression in group A Streptococcus.

Authors:  Jeanette Treviño; Zhuyun Liu; Tram N Cao; Esmeralda Ramirez-Peña; Paul Sumby
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

3.  Identification of rocA, a positive regulator of covR expression in the group A streptococcus.

Authors:  Indranil Biswas; June R Scott
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

4.  Natural disruption of two regulatory networks in serotype M3 group A Streptococcus isolates contributes to the virulence factor profile of this hypervirulent serotype.

Authors:  Tram N Cao; Zhuyun Liu; Tran H Cao; Kathryn J Pflughoeft; Jeanette Treviño; Jessica L Danger; Stephen B Beres; James M Musser; Paul Sumby
Journal:  Infect Immun       Date:  2014-02-10       Impact factor: 3.441

5.  RocA truncation underpins hyper-encapsulation, carriage longevity and transmissibility of serotype M18 group A streptococci.

Authors:  Nicola N Lynskey; David Goulding; Magdalena Gierula; Claire E Turner; Gordon Dougan; Robert J Edwards; Shiranee Sriskandan
Journal:  PLoS Pathog       Date:  2013-12-19       Impact factor: 6.823
  5 in total
  7 in total

1.  RocA Is an Accessory Protein to the Virulence-Regulating CovRS Two-Component System in Group A Streptococcus.

Authors:  Ira Jain; Eric W Miller; Jessica L Danger; Kathryn J Pflughoeft; Paul Sumby
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

Review 2.  Tissue tropisms in group A Streptococcus: what virulence factors distinguish pharyngitis from impetigo strains?

Authors:  Debra E Bessen
Journal:  Curr Opin Infect Dis       Date:  2016-06       Impact factor: 4.915

3.  RocA Has Serotype-Specific Gene Regulatory and Pathogenesis Activities in Serotype M28 Group A Streptococcus.

Authors:  Paul E Bernard; Priyanka Kachroo; Luchang Zhu; Stephen B Beres; Jesus M Eraso; Zaid Kajani; S Wesley Long; James M Musser; Randall J Olsen
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

Review 4.  Regulatory gene mutation: a driving force behind group a Streptococcus strain- and serotype-specific variation.

Authors:  Poulomee Sarkar; Paul Sumby
Journal:  Mol Microbiol       Date:  2016-12-19       Impact factor: 3.501

5.  Regulatory rewiring confers serotype-specific hyper-virulence in the human pathogen group A Streptococcus.

Authors:  Eric W Miller; Jessica L Danger; Anupama B Ramalinga; Nicola Horstmann; Samuel A Shelburne; Paul Sumby
Journal:  Mol Microbiol       Date:  2015-08-14       Impact factor: 3.501

6.  Single Amino Acid Replacements in RocA Disrupt Protein-Protein Interactions To Alter the Molecular Pathogenesis of Group A Streptococcus.

Authors:  Paul E Bernard; Amey Duarte; Mikhail Bogdanov; James M Musser; Randall J Olsen
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

7.  Phenotypic Variation in the Group A Streptococcus Due to Natural Mutation of the Accessory Protein-Encoding Gene rocA.

Authors:  Poulomee Sarkar; Jessica L Danger; Ira Jain; Laura A Meadows; Christopher Beam; Josette Medicielo; Cameron Burgess; James M Musser; Paul Sumby
Journal:  mSphere       Date:  2018-10-17       Impact factor: 4.389
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.